GlaxoSmithKline Pharmaceuticals Ltd.

NSE: GLAXO | BSE: 500660

GlaxoSmithKline Live Share Price Today, Share Analysis and Chart

Falling Comet

Iran war impact

Based on the company's financial filings and market disclosures up to March 20, 2026, here is the impact assessment of the Iran-Israel war on GlaxoSmithKline Pharmaceuticals Ltd. (GLAXO). ##### 1. Nature of Impact: Minimal to Neutrally Negative T...

2340.00 30.90 (1.34%)

33.44% Fall from 52W High

62,004

NSE+BSE Volume

NSE 25 Mar, 2026 11:57 AM (IST)

Loading... You have run out of DVM views!

Subscribe now to see details

High Financial Strength

- / 100

Mid Valuation

- / 100

Technically Bearish

32.8 / 100

Falling Comet These stocks have good quality scores. However, their weak technicals make them more bearish View Similar Embed DVM

1Yr Price target upside is 31%

GlaxoSmithKline Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Is GlaxoSmithKline Pharmaceuticals Ltd. worth buying?

127 Votes:

Buy 66.14%

Sell 20.47%

Hold 13.39%